JBC Journal of Breast Cancer

Original Article

Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: An Investigational Short-Term Analysis

Kang NK, Sung SY, Kim SH, Jeon YW, Suh YJ, Lee JH.

Published online March 27, 2024
https://doi.org/10.4048/jbc.2023.0296

Original Article

Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer

Lee J, Kim JH, Liu M, Bang A, Olson R, Chang JS.

Published online March 28, 2024
https://doi.org/10.4048/jbc.2024.0004

Original Article

Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery

Yang SH, Tey ML, Zhou S, Nitar P, Mariyah H, Sim Y, Kusumawidjaja G, Chay WY, Yong WF, Wong RX.

Published online February 22, 2024
https://doi.org/10.4048/jbc.2023.0242

Brief Communication

Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus

Shiba S, Harao M, Saito A, Sakuragi M, Kitayama J, Sata N.

Published online February 23, 2024
https://doi.org/10.4048/jbc.2023.0285

Study Protocol

Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response

Ryu JM, Lee H, Han W, Lee HB, Ahn SG, Kim HJ, Park HS, Choi JS, Kim H, Cho WK, Lee JE.

Published online April 16, 2024
https://doi.org/10.4048/jbc.2023.0264

Case Report

Rare Case of a Patient With Erdheim-Chester Disease Presenting With Atypical Breast Involvement

Sprenger F, Pecorari AG, Filho VV, Kluppel ST, Staats AC.

Published online January 23, 2024
https://doi.org/10.4048/jbc.2023.0111

Current Issue April 2024 • vol. 27 no. 2

Original Article

Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: An Investigational Short-Term Analysis

Kang NK, Sung SY, Kim SH, Jeon YW, Suh YJ, Lee JH.

Published online March 27, 2024
https://doi.org/10.4048/jbc.2023.0296

Original Article

Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer

Lee J, Kim JH, Liu M, Bang A, Olson R, Chang JS.

Published online March 28, 2024
https://doi.org/10.4048/jbc.2024.0004

Original Article

Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery

Yang SH, Tey ML, Zhou S, Nitar P, Mariyah H, Sim Y, Kusumawidjaja G, Chay WY, Yong WF, Wong RX.

Published online February 22, 2024
https://doi.org/10.4048/jbc.2023.0242

Brief Communication

Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus

Shiba S, Harao M, Saito A, Sakuragi M, Kitayama J, Sata N.

Published online February 23, 2024
https://doi.org/10.4048/jbc.2023.0285

Study Protocol

Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response

Ryu JM, Lee H, Han W, Lee HB, Ahn SG, Kim HJ, Park HS, Choi JS, Kim H, Cho WK, Lee JE.

Published online April 16, 2024
https://doi.org/10.4048/jbc.2023.0264

Case Report

Rare Case of a Patient With Erdheim-Chester Disease Presenting With Atypical Breast Involvement

Sprenger F, Pecorari AG, Filho VV, Kluppel ST, Staats AC.

Published online January 23, 2024
https://doi.org/10.4048/jbc.2023.0111

Forthcoming Articles

Past Issues

Submit Your
Manuscript to JBC

Editorial Manager®

JBC on

2022

Impact Factor 2.4

Oncology Q4

5-Year Impact Factor 2.7

Journal Citation Indicator Q3

JBC Review Time Period

Editor's Choice

•

Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: An Investigational Short-Term Analysis

•

Survival Outcomes Based on Axillary Surgery in Ductal Carcinoma In Situ: A Nationwide Study From the Korean Breast Cancer Society